Table 1.
Unique proteins identified in the three different clinical conditions: at baseline (T0), after 4 (T4) and 8 weeks (T8) of treatment with rhNGF.
| Gene name | Description | T0 | T4 | T8 |
|---|---|---|---|---|
| AKR1A1 | Alcohol dehydrogenase | + | ||
| CAP1 | Adenylylcyclase-associatedprotein 1 | + | ||
| YWHAB | 14–3–3 protein beta/alpha | + | ||
| ELANE | Neutrophilelastase | + | ||
| ACTBL2 | Beta-actin-like protein 2 | + | ||
| PARK7 | Protein/nucleic acid deglycase DJ-1 | + | ||
| NUCB2 | Nucleobindin-2 | + | ||
| WFDC2 | WAP four-disulfide core domain protein 2 | + | ||
| A1BG | Alpha-1B-glycoprotein | + | ||
| LPO | Lactoperoxidase | + | ||
| SELENBP1 | Selenium-bindingprotein 1 | + |